Professional articles

by EUROIMMUN

Complete IFA automation with AI-enhanced evaluation

Featured on SelectScience

The indirect immunofluorescence assay (IFA) is an essential method in autoantibody diagnostics. The all-in-one device – UNIQO 160 from EUROIMMUN – provides complete ...

AI-enhanced evaluation software for immunofluorescence microscopy

Featured on SelectScience

Artificial intelligence (AI) can significantly enhance the evaluation of fluorescence patterns in indirect immunofluorescence assay (IFA) analyses. The EUROPattern ...

Candida auris An emerging drug-resistant pathogen of global concern

Featured in Clinical Laboratory International

Candida auris (C. auris) is a globally emerging multidrug-resistant fungal pathogen, which spreads easily in health-care facilities and causes high ...

Together at the pulse of neurobiology

Featured in Clinical Laboratory International

A unique portfolio of neurobiomarker tests – The testing landscape for neurological diseases has expanded rapidly in recent years due to the ...

APOE genotype A risk factor for adverse effects from anti-amyloid therapy in Alzheimer’s disease

Featured in Clinical Laboratory International

The apolipoprotein E (APOE) genotype influences the development of Alzheimer’s disease and has recently been found to be a risk factor for side effects ...

Innovations for infectious disease diagnostics

Featured in Practical Patient Care

EUROIMMUN offers an extensive range of test systems for infection diagnostics, including serological assays for antibody determination and PCR-based tests for ...

Serological tests for Crimean- Congo haemorrhagic fever virus aid outbreak management

Featured in Omnia Health

Crimean-Congo haemorrhagic fever (CCHF) is a lifethreatening tick-borne disease that is prioritised by the World Health Organization (WHO) for research and product ...

The growing spectrum of neural autoantibodies and associated syndromes

Autoimmune neurology is a rapidly growing field driven by the ongoing discovery of novel neural autoantibodies associated with recognizable clinical syndromes. These diseases can affect the central, ...

Back to top